The FDA has accepted a supplemental New Drug Application for a once-weekly oral formulation of lenacapavir for HIV preexposure prophylaxis.

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A new pre-exposure prophylaxis (PrEP) drug has shown promise as a ...

A clinical trial underway in South Africa and Uganda has shown that a twice-yearly injection of a new PrEP drug gives young women total protection from HIV infection, according to a July 10 report at ...

The Akwa Ibom government has launched the Long-Acting Pre-Exposure Prophylaxis, LENACAPAVIR (LEN-PrEP) drug, a new HIV ...

ATLANTA — Five years ago, the U.S. government unveiled a plan to end the HIV epidemic by 2030. More than 30,000 people are diagnosed with HIV every year in this country. But this is not a problem for ...

It’s possible to produce a generic version of lenacapavir, a twice-yearly antiretroviral injection that both prevents and treats HIV, for as little as $25 per patient per year, according to a study ...

The Medicines Patent Pool has selected Aurobindo, Cipla and Viatris to make generic versions of GSK's long-acting HIV PrEP drug for low- and middle-income countries. (Getty Images) In an effort to ...

A couple of years ago, Matthew Hurley got the kind of text people fear. It said: “When was the last time you were STD tested?” Someone Hurley had recently had unprotected sex with had just tested ...

After nearly a decade of working as an advocate for HIV and AIDS treatment, Michael Chancley said he came to a sobering realization. “Seeing that people who look like me, who hang out at the same ...

The first step is to conduct an HIV test to anyone seeking PrEP. Once they are HIV negative, then you determine their eligibility for PrEP by ruling out any adverse reaction to the components of the ...

A new pre-exposure prophylaxis (PrEP) drug has shown promise as a once-monthly oral pill to help prevent HIV. PrEP plays a key part in reducing the number of new HIV infections by stopping the virus ...